Page Banner

United States Department of Agriculture

Agricultural Research Service

Research Project: Intervention Strategies to Control and Prevent Disease Outbreaks Caused by Avian Influenza and Other Emerging Poultry Pathogens

Location: Exotic and Emerging Avian Viral Diseases Research Unit

Title: Avian influenza virus RNA extraction

Authors
item Spackman, Erica
item Lee, Scott

Submitted to: Animal Influenza Virus
Publication Type: Book / Chapter
Publication Acceptance Date: February 3, 2014
Publication Date: June 11, 2014
Citation: Spackman, E., Lee, S.A. 2014. Avian influenza virus RNA extraction. In: Spackman, E., editor. Animal Influenza Virus: Methods in Molecular Biology. Volume 1161. London: Humana Press. p. 93-104.

Interpretive Summary: The efficient extraction and purification of viral RNA is critical for down-stream molecular applications whether it is the sensitive and specific detection of virus in clinical samples, virus gene cloning and expression, or quantification of avian influenza (AI) virus by molecular methods from experimentally infected birds. Samples can generally be divided into two types; enriched (e.g. virus stocks) and clinical. Clinical type samples, which may be tissues or swab material, are the most difficult to process due to the complex sample composition and possibly low virus titers. In this chapter two well established procedures for the isolation of AI virus RNA from common clinical specimen types and enriched virus stocks for further molecular applications will be presented.

Technical Abstract: The efficient extraction and purification of viral RNA is critical for down-stream molecular applications whether it is the sensitive and specific detection of virus in clinical samples, virus gene cloning and expression, or quantification of avian influenza (AI) virus by molecular methods from experimentally infected birds. Samples can generally be divided into two types; enriched (e.g. virus stocks) and clinical. Clinical type samples, which may be tissues or swab material, are the most difficult to process due to the complex sample composition and possibly low virus titers. In this chapter two well established procedures for the isolation of AI virus RNA from common clinical specimen types and enriched virus stocks for further molecular applications will be presented.

Last Modified: 11/25/2014
Footer Content Back to Top of Page